CVE-2022-26389

Feb. 7, 2025, 5:15 p.m.

7.7
High

Description

An improper access control vulnerability may allow privilege escalation.This issue affects:  * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior;  * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior;  * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior;  * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

Product(s) Impacted

Product Versions
ELI 380 Resting Electrocardiograph
  • ['2.6.0 and prior']
ELI 250c/BUR 250c Resting Electrocardiograph
  • ['2.1.2 and prior']
ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph
  • ['2.2.0 and prior']
ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph
  • ['2.3.1 and prior']

Weaknesses

Common security weaknesses mapped to this vulnerability.

CWE-284
Improper Access Control
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.

References

https://hillrom.com/en/responsible-disclosures/
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-167-01

Tags

CWE-284
productsecurity@baxter.com
2025-02-07
CVE-2022-26389

CVSS Score

7.7 / 10

CVSS Data - 3.1

  • Attack Vector: NETWORK
  • Attack Complexity: HIGH
  • Privileges Required: LOW
  • Scope: CHANGED
  • Confidentiality Impact: LOW
  • Integrity Impact: LOW
  • Availability Impact: HIGH

    • CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H

    View Vector String

Timeline

Published: Feb. 7, 2025, 5:15 p.m.
Last Modified: Feb. 7, 2025, 5:15 p.m.

Status : Awaiting Analysis

CVE has been recently published to the CVE List and has been received by the NVD.

More info

Source

productsecurity@baxter.com

*Disclaimer: Some vulnerabilities do not have an associated CPE. To enhance the data, we use AI to infer CPEs based on CVE details. This is an automated process and might not always be accurate.